Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2025)

Axsome Therapeutics' Amortization - Intangibles history spans 4 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles changed 0.0% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $6.4 million, changed 0.27%, while the annual FY2025 figure was $6.4 million, 0.27% changed from the prior year.
  • Amortization - Intangibles for Q4 2025 was $1.6 million at Axsome Therapeutics, roughly flat from $1.6 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.6 million in Q4 2022 and bottomed at $926000.0 in Q2 2022.
  • The 4-year median for Amortization - Intangibles is $1.6 million (2024), against an average of $1.6 million.
  • The largest annual shift saw Amortization - Intangibles soared 71.6% in 2023 before it fell 1.07% in 2025.
  • A 4-year view of Amortization - Intangibles shows it stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Amortization - Intangibles are $1.6 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025).